BPC-157 + TB-500 + GHK-Cu + KPV-10 KLOW Blend

The BPC-157 + TB-500 + GHK-Cu + KPV-10 Blend is a formulation containing four peptides in a single lyophilized vial. The components include BPC-157, a fragment of Thymosin Beta-4 (TB-500), GHK-Cu, and KPV (Lys-Pro-Val). Each peptide has been studied for its distinct mechanism of action. BPC-157 has been associated with angiogenesis and cytoprotection in research models. TB-500 is involved in cellular migration. GHK-Cu is reported to influence extracellular matrix synthesis and gene expression. KPV is the C-terminal tripeptide of α-MSH and has been investigated for its properties related to inflammation.

This blend contains a total of 80mg of material (BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, KPV 10mg) and is intended for laboratory research investigating processes such as inflammation, cell migration, and extracellular matrix biology. KPV has attracted research attention for its observed modulation of NF-κB signaling in certain models.

By combining four peptides into one formulation, researchers can study multiple molecular pathways without managing separate materials, which may support more reproducible experimental conditions.

The four peptides in this blend are associated with distinct molecular pathways involved in cellular processes such as inflammation, cellular recruitment, and extracellular matrix synthesis.

KPV Pathways

KPV (Lys-Pro-Val) is the C-terminal tripeptide of α-melanocyte-stimulating hormone. It is reported to downregulate NF-κB signaling and reduce the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 in certain in vitro models. It has also been studied for its effects on mucosal tissue in colitis models and for its antimicrobial activity against several pathogenic organisms.

Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

Laboratory Handling

Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

Research Limitations

Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.